FIELD: medicine.
SUBSTANCE: method involves administering Tamoxifen and Zoladex during the whole therapy course.
EFFECT: cut-off ovary functioning; inhibiting estrogen action upon tumor tissue; no adverse side effects observed.
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PHARMACOLOGICAL HEALING WOMEN WITH DESMOID FIBROMA | 2000 |
|
RU2179019C1 |
METHOD FOR TREATING HYPERPLASTIC ENDOMETRIAL PROCESSES COMBINED WITH UTERINE MYOMA | 2006 |
|
RU2317103C1 |
METHOD FOR PREDICTING RELAPSES IN SKIN MELANOMA PATIENTS | 2004 |
|
RU2275637C2 |
APPLICATION OF 9-OCOACRIDINE-10-ACETIC ACID AND/OR ITS SALT COMBINED WITH ANTIESTROGEN AND/OR PROGESTIN FOR TREATMENT OF STROGEN-DEPENDENT TUMOURS, METHOD OF TREATMENT AND SETS | 2007 |
|
RU2346691C2 |
PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING PROLIFERATIVE MAMMARY GLAND DISEASES | 2005 |
|
RU2318508C2 |
METHOD AND REMEDY FOR TREATING BENIGN HYPERPLASIA PROCESSES IN ENDOMETRIUM | 2004 |
|
RU2275194C1 |
MEDICINAL PREPARATION CONTAINING AROMATASE STEROID INHIBITOR FOR PROPHYLAXIS AND/OR TREATMENT OF MAMMARY CANCER | 1999 |
|
RU2225206C2 |
METHOD FOR CORRECTION OF HYPERESTRADIOLEMIA AND NORMOGONADOTROPIC HYPOGONADISM IN MALES | 2010 |
|
RU2474424C2 |
METHOD FOR PREVENTION OF HORMONE RESISTANCE IN ENDOMETRIAL HYPERPLASIA | 2010 |
|
RU2445962C1 |
METHOD FOR PROPHYLAXIS AND TREATMENT OF ESTROGEN-DEPENDENT DISEASES AND DISORDERS | 1998 |
|
RU2214236C2 |
Authors
Dates
2007-10-10—Published
2006-06-20—Filed